Literature DB >> 6176093

Hemodynamics following normovolemic hemodilution in elderly patients.

B Roseberg, K Wulff.   

Abstract

The hemodynamic effects of acute hemodilution with dextran 70 as dilutional agent were evaluated in a group of elderly patients (mean age 68, range 60-79 years) anesthetized with neurolept analgesia. The isovolemic exchange of 1.1 liter of blood (mean) with a 6% solution of dextran 70 decreased the hematocrit value from 41 to 28%. As cardiac index did not exchange, the oxygen transport capacity was significantly reduced. The main compensating mechanism for this was an increased extraction of oxygen in the tissues and, to a minor extent, a raised arterial oxygen tension. The results of this study suggest that intentional hemodilution should be used with caution in aged patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6176093     DOI: 10.1111/j.1399-6576.1981.tb01674.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  4 in total

Review 1.  [Normovolemic hemodilution].

Authors:  D J Cŏté
Journal:  Can J Anaesth       Date:  1991-03       Impact factor: 5.063

2.  Pulmonary gas exchange capacity is reduced during normovolaemic haemodilution in healthy human subjects.

Authors:  C Le Merre; M Dauzat; P Poupard; R Targhetta; C Fabre; S Bouges; J J Eledjam; P Balmès
Journal:  Can J Anaesth       Date:  1996-07       Impact factor: 5.063

3.  Intra-operative acute isovolemic hemodilution is safe and effective in eliminating allogeneic blood transfusions during right hepatic lobectomy: comparison of living donor versus non-donors.

Authors:  C H Rhim; L B Johnson; K Kitisin; A D Lu; T Fishbein; L Broseker; J Yosaitis; J Manley; J S Plotkin
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

Review 4.  Perioperative haemotherapy: I. Indications for blood component transfusion.

Authors:  E T Crosby
Journal:  Can J Anaesth       Date:  1992-09       Impact factor: 5.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.